Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buspirone for levodopa-induced dyskinesia in Parkinson's disease
2014-005422-35Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of buspirone in levodopa-induced dyskinesia (LID) and Parkinson's disease (PD) (2 arms), sponsored by Imperial College London. Started Apr 2015; status: completed.
02
Drugs
buspirone
03
Conditions
levodopa-induced dyskinesia (LID)Parkinson's disease (PD)
Beyond the preview
Go deeper on 2014-005422-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005422-35.